These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 36463144

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Hepatoprotective effects of vildagliptin mitigates lung biochemical and histopathological changes in experimental hepatopulmonary syndrome model in rat.
    Mangoura SA, Ahmed MA, Hamad N, Zaka AZ, Khalaf KA.
    Int Immunopharmacol; 2024 Dec 25; 143(Pt 1):113254. PubMed ID: 39353392
    [Abstract] [Full Text] [Related]

  • 43. [Experimental models for assessment of pulmonary alterations in hepatopulmonary syndrome].
    Vercelino R, Tieppo J, Forgiarini Junior LA, Dias AS, Marroni CA, Marroni NP.
    J Bras Pneumol; 2008 Jul 25; 34(7):453-60. PubMed ID: 18695789
    [Abstract] [Full Text] [Related]

  • 44. Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.
    Zhang HY, Han DW, Su AR, Zhang LT, Zhao ZF, Ji JQ, Li BH, Ji C.
    World J Gastroenterol; 2007 Dec 21; 13(47):6385-95. PubMed ID: 18081228
    [Abstract] [Full Text] [Related]

  • 45. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats.
    Sztrymf B, Rabiller A, Nunes H, Savale L, Lebrec D, Le Pape A, de Montpreville V, Mazmanian M, Humbert M, Hervé P.
    Eur Respir J; 2004 May 21; 23(5):752-8. PubMed ID: 15176692
    [Abstract] [Full Text] [Related]

  • 46. [Inhibitory effect of angiotensin (1-7) on hepatic sinusoid angiogenesis in bile duct ligation-induced hepatic fibrosis of rats].
    Ning ZW, Zhang WY, Li Y, Cai SM, Zhang LL, Li X.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Dec 21; 21(12):907-13. PubMed ID: 24636292
    [Abstract] [Full Text] [Related]

  • 47. Fish omega-3 fatty acids induce liver fibrosis in the treatment of bile duct-ligated rats.
    Chen CC, Ho CY, Chaung HC, Tain YL, Hsieh CS, Kuo FY, Yang CY, Huang LT.
    Dig Dis Sci; 2013 Feb 21; 58(2):440-7. PubMed ID: 23203732
    [Abstract] [Full Text] [Related]

  • 48. Quercetin Mitigates Hepatic Insulin Resistance in Rats with Bile Duct Ligation Through Modulation of the STAT3/SOCS3/IRS1 Signaling Pathway.
    Khodarahmi A, Eshaghian A, Safari F, Moradi A.
    J Food Sci; 2019 Oct 21; 84(10):3045-3053. PubMed ID: 31529802
    [Abstract] [Full Text] [Related]

  • 49. Effects of the nitric oxide donor molsidomine on the early stages of liver damage in rats with bile duct ligation: a biochemical and immunohistochemical approach.
    Oztürk H, Yağmur Y, Buyukbayram H, Dokucu AI, Gurel A.
    Eur Surg Res; 2002 Oct 21; 34(4):285-90. PubMed ID: 12145554
    [Abstract] [Full Text] [Related]

  • 50. Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury.
    Chen B, Ning JL, Gu JT, Cui J, Yang Y, Wang Z, Zeng J, Yi B, Lu KZ.
    Liver Int; 2015 Apr 21; 35(4):1373-82. PubMed ID: 25113058
    [Abstract] [Full Text] [Related]

  • 51. TNF-α neutralization improves experimental hepatopulmonary syndrome in rats.
    Liu L, Liu N, Zhao Z, Liu J, Feng Y, Jiang H, Han D.
    Liver Int; 2012 Jul 21; 32(6):1018-26. PubMed ID: 22672643
    [Abstract] [Full Text] [Related]

  • 52. T1rho MR imaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model.
    Wang YX, Yuan J, Chu ES, Go MY, Huang H, Ahuja AT, Sung JJ, Yu J.
    Radiology; 2011 Jun 21; 259(3):712-9. PubMed ID: 21436087
    [Abstract] [Full Text] [Related]

  • 53. [Molecular mechanism of tumor necrosis factor-alpha monoclonal antibody in hepatopulmonary syndrome in rats].
    Huang X, Liu LI, Liu N.
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jun 21; 23(6):458-63. PubMed ID: 26236934
    [Abstract] [Full Text] [Related]

  • 54. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome.
    Fallon MB, Abrams GA, Luo B, Hou Z, Dai J, Ku DD.
    Gastroenterology; 1997 Aug 21; 113(2):606-14. PubMed ID: 9247483
    [Abstract] [Full Text] [Related]

  • 55. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
    Zhen YZ, Li NR, He HW, Zhao SS, Zhang GL, Hao XF, Shao RG.
    World J Gastroenterol; 2015 Jun 21; 21(23):7155-64. PubMed ID: 26109801
    [Abstract] [Full Text] [Related]

  • 56. Quercetin improves bone strength in experimental biliary cirrhosis.
    Derakhshanian H, Ghadbeigi S, Rezaian M, Bahremand A, Javanbakht MH, Golpaie A, Hosseinzadeh P, Tajik N, Dehpour AR.
    Hepatol Res; 2013 Apr 21; 43(4):394-400. PubMed ID: 22882531
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model.
    Sant'Anna LB, Cargnoni A, Ressel L, Vanosi G, Parolini O.
    Cell Transplant; 2011 Apr 21; 20(3):441-53. PubMed ID: 20719087
    [Abstract] [Full Text] [Related]

  • 60. Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats.
    Ko MT, Huang HC, Lee WS, Chuang CL, Hsin IF, Hsu SJ, Lee FY, Chang CC, Lee SD.
    J Chin Med Assoc; 2017 Aug 21; 80(8):467-475. PubMed ID: 28676445
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.